Apple’s going quiet in 2026, at least by its usual standards. After flooding the market with three new Apple Watch models last year, the company is expected to ship just one new smartwatch this fall: the Apple Watch Series 12. Before you assume that means a boring year, hold on. The rumor mill suggests Apple has something genuinely interesting cooking under the surface, and it’s not what most people would expect from a health-focused wearable.
The biggest hint? A biometric sensor that has nothing to do with tracking your heart rate or blood oxygen levels. According to reporting from Bloomberg’s Mark Gurman, Apple has been experimenting with Touch ID for the wrist. Not for selfies, not for a camera, but for authentication. It’s a feature that vanished from iPhones years ago, and now it might finally make its way to your wrist.
When You’ll Actually See It
If history holds, Apple will unveil the Series 12 sometime in mid-September 2026. The second Tuesday of the month, September 15, looks like the safe bet, though September 9 is also plausible if the company decides to shift things earlier. Preorders would likely follow that Friday, with devices hitting shelves roughly a week later, assuming no supply chain chaos derails the timeline.
Pricing should stay roughly where it is now. The current Series 11 starts around $400 for the 42mm Wi-Fi model, and there’s no strong indication that will change dramatically. That said, lingering tariff increases and potential supply chain hiccups could nudge prices upward if Apple feels pressured.
The Touch ID Question Nobody Asked For
Here’s where things get interesting. According to lines of internal code recently spotted by Macworld, Apple has been testing something called “AppleMesa,” the company’s internal code name for watch-based Touch ID. The specifics remain fuzzy: we don’t know if the sensor would sit under the display like many Android phones, or if it’ll be built into the Digital Crown or side button instead.
It’s an odd choice for a wearable, admittedly. Most people think of Apple Watch biometrics and picture health sensors. But authentication on your wrist could actually make sense. It could streamline payments, app access, or unlock features that currently require your iPhone. Whether Apple actually ships this feature this year remains unclear, but the code suggests serious internal work is happening.
Everything Else We’re Expecting (and Not)
A major design overhaul? Don’t count on it. According to reporting from Bloomberg, Mark Gurman confirmed that no significant visual changes are expected for this year’s lineup. Same silhouette, similar color palette, familiar materials. That’s par for the course with Apple’s watch strategy: incremental refinement rather than revolution.
What could change is the display technology. A more efficient LTPO panel with better brightness could squeeze extra battery life without adding bulk. That matters because battery life remains the most requested upgrade year after year. The Series 11 and Ultra 3 already saw meaningful improvements over their predecessors, but there’s still substantial room to grow.
The processor situation gets a bit awkward. Normally the naming matches the watch number, which would suggest an S12 chip. But since the Series 11 and Ultra 3 are still running the older S10, the next upgrade could technically be an S11. Don’t expect a huge leap in raw performance either way. Most of the gains will probably come from smarter software optimization and more efficient architecture.
The Health Features That Might (or Might Not) Arrive
Apple has already started dipping into blood pressure monitoring through hypertension notifications on newer watches. But these are alerts, not actual readings. The company has been testing on-the-spot blood pressure measurement according to Gurman, though accuracy issues have been a persistent stumbling block. Even if Apple cracks that problem this year, the feature might only track baseline trends rather than provide real-time numbers, similar to what Samsung offers on the Galaxy Watch 7 and Ultra.
Glucose monitoring is another long-running rumor, but it’s apparently further from ready than blood pressure. Expect that one in 2027 at the earliest, if it happens at all.
Then there’s the mysterious “Project Mulberry,” Bloomberg’s reporting on Apple’s secret health app overhaul. The company has been working on an AI-powered health concierge that could unify your fitness, health, and medical data in one place. Sounds ambitious. Sounds like it hit some roadblocks too. According to Gurman’s latest reporting, Apple has put the effort on hold for now, at least for this year.
What About WatchOS 27?
Following Apple’s rebranding convention, the next major Technology update will be WatchOS 27. A dramatic visual redesign isn’t in the cards since the last major overhaul already happened. Instead, look for incremental improvements: better battery management tools, more customizable gesture controls, maybe an expanded Workout Buddy feature that moves beyond just cheerleading metrics.
A symptom tracker tied into the Vitals app similar to Oura Ring’s approach would be genuinely useful. Something that could flag early illness signs before they become serious. Apple’s health ecosystem is powerful but scattered across different apps. Consolidating that would be genuinely valuable, even if it doesn’t generate headlines.
The Bigger Picture
What’s actually interesting about 2026 isn’t what’s coming, but what’s being held back. Apple could’ve packed the Series 12 with every experimental feature it’s tested. Instead, the company seems to be moving carefully. Touch ID is a bold move for a smartwatch, but blood pressure monitoring and glucose tracking apparently aren’t ready. The health concierge got shelved. Even the display improvements seem incremental rather than revolutionary.
That’s either cautious product management or it’s a sign that the innovation pipeline for wearables is harder to fill than Apple expected. Either way, the question isn’t whether the Series 12 will be worth buying, but whether Apple is still pushing the category forward or just filling a release schedule.
